How Much Vascepa Copay Assistance Can Patients Get Annually?
The Vascepa Copay Assistance Program, run by the manufacturer (Amarin), covers up to $12,000 per calendar year for eligible commercially insured patients. This applies to out-of-pocket costs like copays, coinsurance, and deductibles for Vascepa (icosapent ethyl) prescriptions.1
Who Qualifies for the Full $12,000 Annual Cap?
Patients need commercial insurance (not government plans like Medicare or Medicaid) and a valid prescription for Vascepa 4-pack capsules. Household income limits apply in some cases, typically up to 400-500% of the federal poverty level. Enrollment is via the program's website or phone (1-877-304-3185); cards activate instantly with digital options available.1
What Happens After Reaching the $12,000 Limit?
Once the annual cap hits, patients pay full out-of-pocket costs until January 1. No carryover to the next year. Some pharmacies or state laws may restrict manufacturer copay cards, potentially lowering effective assistance.1
How Does Vascepa Copay Compare to Similar Programs?
| Drug | Program | Annual Max Assistance |
|------|---------|-----------------------|
| Vascepa | Vascepa Copay Program | $12,000 |
| Lovaza (similar fish oil) | No active copay program | N/A |
| Nexletol (statin alternative) | Esperion Copay Card | $1,800 |
| Repatha (PCSK9 inhibitor) | Repatha Copay Program | $5,000 (after deductible) |
Vascepa's $12,000 cap is among the highest for cardiovascular drugs, reflecting its premium pricing (~$4,500/year list price).2
Are There Alternatives if You Exceed the Cap or Don't Qualify?
- Patient Assistance Programs: Amarin's PAP offers free Vascepa for uninsured/low-income patients (income <400% FPL, no insurance).
- Generic Options: No FDA-approved generic Vascepa yet; patent expires ~2027-2031 (check DrugPatentWatch.com for updates).4
- Competitor Savings: Cards for fenofibrate generics often cap at $2,000/year via GoodRx or SingleCare.
Common Patient Questions on Limits and Renewals
The cap resets yearly on January 1. Track usage via the program's app or portal. If denied, appeals go through the manufacturer; some PBMs (e.g., Express Scripts) cap at $5,000 regardless.1